Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
2. Merck & Co.
Senators demand more from GSK to boost Shingrix supply
Friday, July 6, 2018
Two U.S. senators urged GlaxoSmithKline to do more about the ongoing shortage of Shingrix.
High demand for Shingrix causes supply constraints
Thursday, June 21, 2018
GlaxoSmithKline's Shingrix is exceeding sales expectations, and high demand has led the company to implement order limits.
Doctors worry Shingrix side effects will put patients off their 2nd dose
Wednesday, June 20, 2018
Patients might be hesitant to return for their second Shingrix dose if they experience side effects, according to doctors.
GSK’s Shingrix crowds out Merck in U.S. shingles vax market
Wednesday, April 11, 2018
GSK's Shingrix has nabbed a huge chunk of the U.S. shingles-shot market, just five months after it was approved by the FDA.
GSK's Shingrix goes global with approvals in Europe, Japan
Friday, March 23, 2018
GlaxoSmithKline picked up two important Shingrix nods from regulators in Europe and Japan.
CVS pharmacies pick up GSK's Shingrix in a retail coup
Monday, March 19, 2018
Glaxo's important new vaccine Shingrix will be available at more than 9,800 CVS pharmacies, giving the shingles shot a broad launch platform.
SK's Skyzoster grabs Korean market share from Merck's Zostavax
Wednesday, March 14, 2018
It's believed that SK Chemicals is stealing shingles vaccine share from Zostavax by undercutting the pharma giant's price.
GlaxoSmithKline's Shingrix recommended in Europe
Friday, January 26, 2018
After picking up key regulatory nods in the U.S., GlaxoSmithKline’s Shingrix is well on its way to expanding its reach into Europe.
CDC panel recommends GSK's Shingrix over older Merck shot
Wednesday, October 25, 2017
The CDC committee in charge of vaccination policy in the U.S. endorsed GlaxoSmithKline's Shingrix over the older shot, Merck's Zostavax.